Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2795 SEK | -2.78% |
|
-3.12% | -97.20% |
05-22 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |